These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6830690)

  • 1. Cell fusion segregates progressive growth from metastasis.
    Sidebottom E; Clark SR
    Br J Cancer; 1983 Mar; 47(3):399-405. PubMed ID: 6830690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the metastatic properties of B16 melanoma clones isolated from cultured cell lines, subcutaneous tumors, and individual lung metastases.
    Poste G; Doll J; Brown AE; Tzeng J; Zeidman I
    Cancer Res; 1982 Jul; 42(7):2770-8. PubMed ID: 7083167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of cell fusion to analyse factors involved in tumour cell metastasis.
    Ramshaw IA; Carlsen S; Wang HC; Badenoch-Jones P
    Int J Cancer; 1983 Oct; 32(4):471-8. PubMed ID: 6684641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of tumor cell heterogeneity during progressive growth of individual lung metastases.
    Poste G; Tzeng J; Doll J; Greig R; Rieman D; Zeidman I
    Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6574-8. PubMed ID: 6959137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of phenotypic diversity in the B16 mouse melanoma relative to spontaneous metastasis.
    Stackpole CW
    Cancer Res; 1983 Jul; 43(7):3057-65. PubMed ID: 6850615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells.
    Poste G; Doll J; Fidler IJ
    Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6226-30. PubMed ID: 6947225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective suppression of metastasis but not tumorigenicity of a mouse lung carcinoma by cell hybridization.
    Layton MG; Franks LM
    Int J Cancer; 1986 May; 37(5):723-30. PubMed ID: 3699933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional emergence of metastatic heterogeneity in a growing tumor.
    Raz A
    Cancer Lett; 1982; 17(2):153-60. PubMed ID: 7165871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of collagenase IV (basement membrane collagenase) activity in murine tumor cell hybrids that differ in metastatic potential.
    Turpeenniemi-Hujanen T; Thorgeirsson UP; Hart IR; Grant SS; Liotta LA
    J Natl Cancer Inst; 1985 Jul; 75(1):99-103. PubMed ID: 2989606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell.
    Fidler IJ; Talmadge JE
    Cancer Res; 1986 Oct; 46(10):5167-71. PubMed ID: 3756870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant potential of cells isolated from lymph node or brain metastases of melanoma patients and implications for prognosis.
    Zhang RD; Price JE; Schackert G; Itoh K; Fidler IJ
    Cancer Res; 1991 Apr; 51(8):2029-35. PubMed ID: 1826230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of tumorigenic and metastatic potentials of human melanoma cell lines by mutated (143 Val-Ala) p53.
    Rauth S; Green A; Kichina J; Shilkaitis A
    Br J Cancer; 1998 Jun; 77(12):2215-22. PubMed ID: 9649136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The gangliosides as a possible molecular coupling factor between the proportion of radiosensitive cells in vitro and the metastatic potential in vivo within a human melanoma cell line.
    Thomas CP; Buronfosse A; Portoukalian J; Fertil B
    Br J Cancer; 1997; 75(5):639-49. PubMed ID: 9043018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastasis results from preexisting variant cells within a malignant tumor.
    Fidler IJ; Kripke ML
    Science; 1977 Aug; 197(4306):893-5. PubMed ID: 887927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T24 HRAS transformed NIH/3T3 mouse cells (GhrasT-NIH/3T3) in serial tumorigenic in vitro/in vivo passages give rise to increasingly aggressive tumorigenic cell lines T1-A and T2-A and metastatic cell lines T3-HA and T4-PA.
    Ray DB; Merrill GA; Brenner FJ; Lytle LS; Lam T; McElhinney A; Anders J; Rock TT; Lyker JK; Barcus S; Leslie KH; Kramer JM; Rubenstein EM; Pryor Schanz K; Parkhurst AJ; Peck M; Good K; Granath KL; Cifra N; Detweiler JW; Stevens L; Albertson R; Deir R; Stewart E; Wingard K; Richardson MR; Blizard SB; Gillespie LE; Kriley CE; Rzewnicki DI; Jones DH
    Exp Cell Res; 2016 Jan; 340(1):1-11. PubMed ID: 26254261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice.
    Kozlowski JM; Hart IR; Fidler IJ; Hanna N
    J Natl Cancer Inst; 1984 Apr; 72(4):913-7. PubMed ID: 6584666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between the radiosensitivity in vitro of clones and variants derived from a human melanoma cell line and their spontaneous metastatic potential in vivo.
    Thomas CP; Buronfosse A; Portoukalian J; Fertil B
    Cancer Lett; 1995 Jan; 88(2):221-5. PubMed ID: 7874696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A primary observation on the effect of cell fusion on metastatic potential of tumor cells].
    Wang R; Yan Y; Wu H; Sheng Q; Liu H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Jun; 17(3):214-8. PubMed ID: 8706158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of tumorigenicity in interspecific reconstituted cells and cybrids.
    Koura M; Isaka H; Yoshida MC; Tosu M; Sekiguchi T
    Gan; 1982 Aug; 73(4):574-80. PubMed ID: 7152196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The analysis of malignancy by cell fusion. VIII. Evidence for the intervention of an extra-chromosomal element.
    Jonasson J; Harris H
    J Cell Sci; 1977 Apr; 24():255-63. PubMed ID: 893545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.